ORIGINAL RESEARCH
Accepted on 25 Jul 2025
Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression
doi 10.3389/fimmu.2025.1528594
- 176 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Response/Resistance to PD-1 Axis Inhibitors: Focus on the Tumor Microenvironment
Response/Resistance to PD-1 Axis Inhibitors: Focus on the Tumor Microenvironment
16k
Total downloads
47k
Total views and downloads
Articles
CASE REPORT
Published on 01 May 2025
Case Report: Combined PD-1 and tyrosine kinase blockade stabilizes refractory pancreatic cancer guided by the spatial structure of tumor immune microenvironment
doi 10.3389/fimmu.2025.1547388
- 1,419 views
ORIGINAL RESEARCH
Published on 11 Dec 2024
TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC
doi 10.3389/fimmu.2024.1499731
- 2,632 views
- 1 citation
REVIEW
Published on 03 Dec 2024
Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers
doi 10.3389/fimmu.2024.1487610
- 1,281 views
- 2 citations
ORIGINAL RESEARCH
Published on 02 Dec 2024
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1
doi 10.3389/fimmu.2024.1486888
- 1,514 views
ORIGINAL RESEARCH
Published on 15 Oct 2024
PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop
doi 10.3389/fimmu.2024.1452212
- 2,215 views
- 3 citations
CLINICAL TRIAL
Published on 23 Sep 2024
Opioid−free anesthesia attenuates perioperative immunosuppression by regulating macrophages polarization in gastric cancer patients treated with neoadjuvant PD-1 inhibitor
doi 10.3389/fimmu.2024.1438859
- 1,989 views
- 3 citations
ORIGINAL RESEARCH
Published on 28 Jun 2024
Training immunophenotyping deep learning models with the same-section ground truth cell label derivation method improves virtual staining accuracy
doi 10.3389/fimmu.2024.1404640
- 2,506 views
- 2 citations
CASE REPORT
Published on 31 May 2024
Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report
doi 10.3389/fimmu.2024.1371379
- 1,544 views
- 2 citations
ORIGINAL RESEARCH
Published on 11 Apr 2024
The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy
doi 10.3389/fimmu.2024.1358306
- 1,911 views
- 3 citations
REVIEW
Published on 10 Apr 2024
Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis
doi 10.3389/fimmu.2024.1366489
- 2,232 views
- 2 citations
BRIEF RESEARCH REPORT
Published on 12 Mar 2024
Role of CD38 in anti-tumor immunity of small cell lung cancer
doi 10.3389/fimmu.2024.1348982
- 3,170 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore